Article Information
History
- November 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rajesh Vikkurthi1,†,
- Asgar Ansari1,†,
- Anupama R Pai1,
- Someshwar Nath Jha1,
- Shilpa Sachan1,
- Suvechchha Pandit1,
- Bhushan Nikam1,
- Anurag Kalia1,
- Bimal Prasad Jit2,
- Hilal Ahmad Parray3,
- Savita Singh3,
- Pallavi Kshetrapal3,
- Nitya Wadhwa3,
- Tripti Shrivastava3,
- Poonam Coshic4,
- Suresh Kumar5,
- Pragya Sharma5,
- Nandini Sharma5,
- Juhi Taneja6,
- Anil K Pandey6,
- Ashok Sharma2,
- Ramachandran Thiruvengadam3,
- Alba Grifoni7,
- Shinjini Bhatnagar3,
- Daniela Weiskopf7,
- Alessandro Sette7,8,
- Pramod Kumar Garg3 and
- Nimesh Gupta1,*
- 1Vaccine Immunology Laboratory, National Institute of Immunology, New Delhi, 110067, India
- 2Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, 110029, India
- 3Translational Health Science and Technology Institute, Faridabad, 121001, India
- 4Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India
- 5Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, 110002, India
- 6ESIC Medical College and Hospital, Faridabad, 121012, India
- 7Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA
- 8Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, 92037, USA
- ↵*Corresponding Author:
Dr. Nimesh Gupta, Vaccine Immunology Laboratory, National Institute of Immunology, New Delhi -110067, India. Email: nimesh.gupta{at}nii.ac.in
↵† These authors have contributed equally to this work.
Posted November 15, 2021.
Inactivated virus vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern
